ArticleCJC open2026
Temporal Trends in Hospitalization and Interventions for Aortic Stenosis in Canada, 2012-2024.
Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Given the paradigm shift from surgical aortic valve replacement (SAVR) to transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), we examined the temporal trends in AS hospitalization and treatment across Canada. Methods: Data from the Canadian Institute for Health Information Discharge Abstract Database were used for a population-based cross-sectional study of inpatients between April 1, 2012, and March 31, 2024. We estimated national and provincial rates and reported the annual changes in hospitalization for AS, SAVR, and TAVI. Rates were expressed as episodes/procedures per million, and stratified by age group, sex, and urban-vs-rural residence. Results: Between 2012 and 2024, hospitalizations for AS increased from 259.8 to 362.4 per million. Rates of SAVR declined from 104.4 to 66.5 per million, whereas rates of TAVI rose from 19.0 to 136.9 per million. The average annual per-million increases in AS hospitalizations were highest in Prince Edward Island (25.0), Nova Scotia (22.9), and Newfoundland and Labrador (21.3), particularly among individuals ≥ 80 years of age. The rates of SAVR declined, as the uptake of TAVI increased, with the shift mostly evident in those 60-79 years of age. Rates of TAVI were higher in men than in women, whereas AS hospitalizations were higher in rural than in urban areas. Conclusions: Not unexpectedly there has been a dramatic shift from SAVR to TAVI observed, with an overall improvement in access to care. Nevertheless, sex-related and geographic disparities persist, highlighting the need for a coordinated national effort to ensure equitable access to AS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.